J

Jupiter Bioscience

JUPITER

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

2
  • Stock is trading at 0.03 times its book value
  • Company has delivered good profit growth of 22.8% CAGR over last 5 years

Weaknesses

2
  • Tax rate seems low
  • Company has a low return on equity of 9.58% over last 3 years.

Growth Rate

Revenue Growth
42% higher than 3Y
Net Income Growth
21% higher than 3Y

Profit & Loss

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011
Sales
91
121
154
178
233
331
Expenses
49
70
86
90
113
185
Operating Profit
42
51
68
88
119
146
OPM %
46%
42%
44%
50%
51%
44%
Other Income
0
0
1
2
0
0
Interest
7
8
13
19
26
29
Depreciation
12
16
22
33
44
59
PBT
23
27
34
38
49
58
Tax %
21%
25%
14%
12%
13%
12%
Net Profit
18
20
30
33
42
51
EPS in Rs
—
20.51
16.4
20.48
26.33
8.23
Div. Payout %
12%
11%
12%
10%
9%
13%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011
Equity Capital
9
10
18
16
18
65
Reserves
107
161
291
319
390
789
Borrowings
114
180
200
301
427
455
Other Liabilities
22
21
30
34
37
56
Total Liabilities
252
371
539
670
873
1,364
Fixed Assets
96
143
241
317
408
513
CWIP
42
81
123
146
217
259
Investments
1
1
1
10
18
301
Other Assets
114
146
174
198
231
291
Total Assets
252
371
539
670
873
1,364
Figures in ₹ Crores

Cash Flow

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011
Operating
32
18
48
68
92
118
Investing
-57
-105
-163
-143
-220
-514
Financing
25
88
115
74
133
395
Net Cash Flow
0
1
0
-1
5
-2
Free Cash Flow
-10
-86
-114
-64
-114
-90
CFO/OP
88
50
76
82
84
89
Figures in ₹ Crores

Ratios

Particulars Mar 2006Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011
Debtor Days
81
87
94
102
92
90
Inventory Days
190
316
354
418
346
221
Days Payable
34
35
34
51
50
29
Cash Conversion Cycle
237
368
413
470
388
282
Working Capital Days
122
190
213
239
225
187
ROCE %
—
12%
11%
10%
10%
8%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Jupiter Bioscience insights

48 extracted metrics + investor summaries across FY06–FY11.

Log in — free

Documents

Frequently Asked Questions about Jupiter Bioscience

What does Jupiter Bioscience Ltd do?
Jupiter Bioscience Limited manufactures drug intermediates, specialty and fine chemicals, bulk drugs, and nutraceuticals primarily in India. The company offers aminoacids and its derivatives, including Fmoc-, Boc-, and Z-protected aminoacids, as well as side chain protected aminoacids.
Which sector does Jupiter Bioscience Ltd belong to?
Jupiter Bioscience Ltd is classified under the Commodities sector, in the Chemicals & Petrochemicals industry.

Company Information

Jupiter Bioscience Limited manufactures drug intermediates, specialty and fine chemicals, bulk drugs, and nutraceuticals primarily in India. The company offers aminoacids and its derivatives, including Fmoc-, Boc-, and Z-protected aminoacids, as well as side chain protected aminoacids.

Website jupiterbioscience.com
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/JUPITER.md for Jupiter Bioscience Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Commodities → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List